An update on current pharmacotherapy options in atopic dermatitis

Area of Science:

• Dermatology
• Immunology
• Pharmacology

Background:

• Advances in understanding atopic dermatitis (AD) pathogenesis.
• Emerging therapeutic strategies for AD management.

Purpose of the Study:

• Review current and future treatment options for atopic dermatitis.
• Emphasize long-term treatment outcomes and adherence.

Main Methods:

• Literature review using PubMed as the primary source.
• Analysis of pathogenic factors and treatment efficacy.
• Evaluation of topical and systemic therapies for AD.

Main Results:

• Topical corticosteroids offer short-term relief; topical calcineurin inhibitors (TCIs) provide a better long-term benefit/risk ratio.
• Systemic immunosuppressants like azathioprine, cyclosporine, methotrexate, and mycophenolate mofetil show ~50% improvement in clinical signs.
• Treatment adherence significantly impacts outcomes.

Conclusions:

• Future T(H)2-specific systemic treatments combined with optimal topical TCIs, such as tacrolimus ointment, could achieve complete skin inflammation control in AD.
• Complete AD control may also help manage associated atopic airway diseases.